South Korea sticks to flu vaccine plan despite safety fears after 13 deaths
News/Health: South Korean officials refused to suspend a seasonal influenza inoculation effort on Thursday, despite growing calls for a halt, including an appeal from a key group of doctors, after the deaths of at least 13 of those vaccinated. Health authorities said they found no direct links between the deaths and the vaccines.
Coronavirus vaccines could be available for all Americans by March: HHS Secretary Azar
One or more COVID-19 vaccines could be ready before the end of 2020, but leaders from federal health agencies coordinating the distribution of future vaccines warned it’s still vital for Americans to follow health precautions in the meantime.
The CDC is expanding its definition of 'close contact' when it comes to COVID-19. Here's why
News/Health: U.S. health officials Wednesday redefined what counts as close contact with someone who has COVID-19 to include briefer but repeated encounters. The change was triggered by a study of a correctional officer who was diagnosed with coronavirus after having multiple brief encounters with prisoners who later tested positive.
Diabetics see lower death risk if they drink these beverages daily, study suggests
Coffee and green tea could lower the death risk for type 2 diabetes sufferers — but only if they drink a certain amount, according to a new, observational study published in the online journal BMJ Open Diabetes Research & Care.
Oxford's Brazil vaccine trial to continue after volunteer dies, university says
News/Health: The University of Oxford's Brazilian trial of its vaccine candidate will continue after the death of a volunteer, the university said on Wednesday, adding an independent review had revealed no safety concerns.
Coronavirus surge in North Dakota leaves contact tracing up to residents
North Dakota health officials are asking residents to conduct their own contact tracing if they have tested positive for COVID-19 as a surge in cases of the novel coronavirus has left contact tracers in the state overwhelmed and strapped for resources.
OxyContin maker Purdue reaches plea deal in opioid probe
News/Health: Purdue Pharma, the company that makes OxyContin, the powerful prescription painkiller that experts say helped touch off an opioid epidemic, will plead guilty to three federal criminal charges as part of a settlement of more than $8 billion US, Justice Department officials in the U.S. announced Wednesday.
Lack of antidotes called 'serious ethical dilemma' for COVID-19 vaccine challenge trial
News/Health: Scientists seeking approval to deliberately infect healthy people with COVID-19 in trials must first convince ethics specialists that, among other things, they have potential 'rescue therapies' to halt the disease.
'A long, dark winter': Experts worry about mental health in first full COVID winter
News/Canada/Edmonton: Psychologists have worried about the mental health toll of rising COVID-19 cases and tightened restrictions for months — add in the shorter days and colder weather of the approaching season, and we could be in for what one expert called a "long, dark winter."
3 days without water dehumanizing for residents of Neskantaga First Nation, chief says
News/Canada/Thunder Bay: Residents of Neskantaga First Nation are starting their third day of no running water after the community's water plant was shut down on Monday, and the chief says he cannot see an end to more than 25 years of water problems in the remote community, about 450 kilometres north of Thunder Bay, Ont.
Some Ontario teens starting to adapt to stress from COVID-19 pandemic, research finds
News/Canada/Toronto: According to Kids Help Phone, hundreds of teens are continuing to call and text the service every day to talk about mental health issues, but experts say there are signs that some teens are beginning to adapt to stress from the COVID-19 pandemic.
Why getting COVID-19 vaccines approved in Canada won't be 'overnight solution' to pandemic
News/Canada/Toronto: Ten COVID-19 vaccine candidates are now in Phase 3 clinical trials — the final leg of the process before their potential approval. But experts warn that final stamp won't be an overnight solution.